Skip to main content

Day: April 15, 2022

Ragnarok Labyrinth NFT will be Re-opened in Southeast Asia on April 27, 2022

Seoul, April 15, 2022 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, today announced that its subsidiary in Indonesia, PT Gravity Game Link (“GGL”), will re-open Ragnarok Labyrinth NFT on April 27, 2022 after improving, which was initially launched in Southeast Asia on April 13. Ragnarok Labyrinth NFT applies P2E system to The Labyrinth of Ragnarok, a mobile Time Effective MMOPRG game, and the game is the first NFT title using Ragnarok IP which has high recognition in global including Southeast Asia. The number of pre-registered accounts has surpassed 1 million in 22 days since March 17, 2022 and more than 1.1 million accounts have been signed up in total. After launching in Southeast Asia on April 13, a large number of users from all over the...

Continue reading

Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on April 29, 2022

NEW HAMPTON, N.Y., April 15, 2022 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, April 29th at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO will host the call. First quarter results will be published prior to the market opening on Friday, April 29, 2022. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the...

Continue reading

Verano’s Zen Leaf Elizabeth and Lawrence Dispensaries Ready and Excited to Welcome New Jersey Personal Use Cannabis Customers on April 21

CHICAGO, April 15, 2022 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today celebrated the New Jersey Cannabis Regulatory Commission’s announcement that personal use cannabis sales will commence in the state on Thursday, April 21, 2022. Verano is the sole cannabis company currently permitted to initiate personal use sales in New Jersey’s central region on April 21st at its Zen Leaf Elizabeth (117 Spring St) and Lawrence Township (3256 Brunswick Pike) dispensary locations. The Company also operates Zen Leaf Neptune Township (2100 Route 66), a medical cannabis dispensary that will soon commence adult use sales, along with a state-of-the-art, 120,000 square foot cultivation and processing facility in Branchburg. Quote from George Archos, Verano...

Continue reading

2022 first quarter : Income increase by 55%

Press Release        Ecully, April 15, 2022 – 10 amContinued growth in Q1 2022Q1 2022 revenues up +55%In thousands of euros 2022* 2021 % VariationTurnover Q1 1 342 865 + 55%Unaudited consolidated data In line with the last quarter of 2021, Spineway confirms its growth momentum and totals revenues of €1.3 million for the first quarter of 2022, up 55% compared to the year 2021. The latter benefits from the synergies implemented with Distimp, the growth of sales in France and positive commercial orientation in Latin America. Sales in Latin America showed strong growth of 31.1% compared to 2021 and represented 41.5% of Group sales (€558 k). Despite the continuing health crisis in the territory, the region is benefiting from a return to a more normalized situation in surgical activity, which has enabled the booking of significant...

Continue reading

Michelin: Publication of the preparatory documentation for the Annual Shareholders Meeting of May 13, 2022

Clermont-Ferrand, April 15, 2022 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Publication of the preparatory documentation for the Annual Shareholders Meeting of May 13, 2022 The Annual Meeting of Michelin Shareholders will be held on Friday, May 13, 2022 from 9 a.m. at the Zénith d’Auvergne, 24 rue de Sarliève, 63800 Cournon d’Auvergne, Puy-de-Dôme, France. Shareholders of the Company who wish to attend the Annual Shareholders Meeting in person must comply with the health measures prevailing at the time the meeting is held. Shareholders are invited to regularly consult the Annual Shareholders Meeting section of the Company’s website, www.michelin.com/en, to access all of the up-to-date information about the event. As Michelin shares are exclusively registered shares, all shareholders receive a notice of meeting including...

Continue reading

Campine bids on selected assets of Recylex France

Occasional information – April 15th, 2022 – 08:30 Campine NV, metals recycling and specialty chemicals company from Beerse, Belgium and listed on Euronext Brussels has submitted a binding offer for selected assets of the Recylex S.A. group. Recylex S.A., a French metal recycling company listed on Euronext Paris has been in financial difficulties since several years, which lead mid 2020 to the bankruptcy of its German entities, the main industrial assets of the group. Recylex initiated a debt restructuring process in 2021 in which it seeks to sell several of its remaining French assets. Campine has offered to acquire the lead battery recycling plants in Escaudoeuvres and Villefranche-sur-Saône, France as well as the plastics recycling unit C2P, located on the same site. The 2 Recylex sites employ about 60 people and recycle a total of about...

Continue reading

Preliminary financial results for 03 month of 2022

In March, “Novaturas” group served 14.2 thousand customers, and the group’s revenue amounted to EUR 10.9 million. In total, during January-March, the company served 36.4 thousand customers, 11% less than the same period in pre-pandemic 2019. Cumulative January – March turnover reached EUR 27.6 million and was only by 4% lower than the corresponding time in 2019.  “We are closing the first quarter of this year with solid financial results. In terms of both the number of travelers served and the revenue generated in March, for the first time since the pandemic, we have exceeded the results of the same month of 2019. Compared to March 2019, this year we have served 5% more people and generated 11% more revenues”, says Vitalij Rakovski, head of “Novaturas” group.   The company notes that in the second half of March, the number...

Continue reading

Filing for the opening of Court-ordered reorganization proceedings (“redressement judiciaire”) and the implementation of a disposal plan for the Group’s industrial assets (“prépack cession”), following the failure of the debt restructuring

Recylex S.A. (Euronext Paris: FR0000120388 – RX) (the “Company“) notes, in light of the offers received in the context of the asset disposal process that the Company had initiated in May 2021, that (i) it will not have sufficient financial resources to allow a debt restructuring in an amicable framework, and (ii) it will be impossible to implement the envisaged asset disposal program in an in bonis1 framework. The offers received by the Company to date are as follows:An offer for the Escaudoeuvres and Villefranche-sur-Saône industrial sites and the shares of the subsidiary C2P S.A.S. for less than €2.5 million, allowing the preservation of the business and jobs (60 jobs in total); Two offers for the 50% stake in Recytech S.A. for a total of €40 million, this stake being subject to a first and second ranking pledge in...

Continue reading

Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced that its Annual Report for 2021 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2021 Annual Report by contacting the company by e-mail, ir@immunicum.com. This information is information that Immunicum is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 8:00 am CEST on 15 April 2022.FOR MORE INFORMATION, PLEASE CONTACT: Erik Manting Chief Executive Officer E-mail: ir@immunicum.comINVESTOR RELATIONS Brendan Payne Stern Investor Relations Telephone: +1 212-698-8695 E-mail:...

Continue reading

Leadership changes announced at GrandVision

Leadership changes announced at GrandVision Charenton-le-Pont, France, and Schiphol, The Netherlands (April 15, 2022 – 8 am CEST) – EssilorLuxottica and GrandVision today announce some changes to GrandVision’s management team. Stephan Borchert and Willem Eelman have decided to step down from their roles as Chief Executive Officer and Chief Financial Officer of GrandVision respectively, effective April 22. They will be replaced by Massimiliano Mutinelli as the new President Optical Retail EMEA at EssilorLuxottica and Head of Amsterdam Corporate Offices at GrandVision, and Niccolò Bencivenni as the Chief Financial Officer of GrandVision, supported by Frederic Dauche in his confirmed role as Chief Operating Officer of GrandVision. “I would like to express our most sincere thanks to Stephan and Willem for their strong leadership and significant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.